FAQ
Contact Us
Complaint & Feedback
Sitemap
Image

Download report here

  • Technical Report NHMS 2023
  • NHMS 2023 PENEMUAN UTAMA
  • NHMS 2023 KEY FINDINS
  • fact sheet nhms 2023
  • Lembaran Fakta NHMS 2023
  • Technical Report NHMS MCH 2022
  • NHMS AHS 2022 MALAYSIA REPORT
  • AHS LEMBARAN FAKTA
  • NHMS AHS FACT SHEET
  • NHMS AHS INFOGRAPHIC BM
  • NHMS AHS INFOGRAPHIC BI
  • MCH LEMBARAN FAKTA
  • MCH FACT SHEET
  • NHMS 2022 MCH INFOGRAPHIC BM
  • NHMS 2022 MCH INFOGRAPHIC BI
  • Report NHMS Vol1
  • Report NHMS Vol2
  • Infographic NHMS 2020 - Key Findings
  • Infografik NHMS 2020 - Penemuan Utama
  • Fact Sheet NHMS 2020
  • Lembaran Fakta NHMS 2020
  • Research Highlights NHMS 2020 - Risk Hepatitis B
  • Research Highlights NHMS 2020 - Hepatitis B : A healthy carrier Among Us
  • 3 HIV Stigma FA 001
  • 4 HIV Knowledge FA 001
  • 5 TB Like Symptom FA 001
  • 6 Antibiotic Use FA 001
  • 7 Malaria FA 001
  • 8 Dengue Search And Destroy FA 001
  • 9 Dog Ownership Zoonosis FA 001
  • 10 Dog Bite Injuries Zoonosis FA 001
  • Report NHMS 2019 Healthcare Demand
  • Report NHMS 2019 NCD
  • Fact Sheet NHMS 2019 - English
  • Fact Sheet NHMS 2019 - BM
  • Infographic Booklet NHMS 2019 - English
  • Infographic Booklet NHMS 2019 - BM
  • 2018infographic
  • 2018 Factsheet 2
  • 2018 Factsheet 1
  • 2018 2
  • 2018 1
  • 2017infographic
  • 2017 3
  • 2017 2
  • 2017 1
  • 2016 2
  • 2016 1
  • 2015 5
  • 2015 4
  • 2015 3
  • 2015 2
  • 2015 1
  • 2014 2
  • 2014 1
  • 2012 2
  • 2012 1
  • 2011 3
  • 2011 2
  • 2011 1
  • 2003

    What isNHMS ?

    NHMS is a health survey at community level across the country to get information on the health status of Malaysians. The purpose of this survey is to obtain information on communicable diseases in Malaysia including health status related to Hepatitis B and C infections. This survey will also assess respondent`s cognitive, affective and behavioral (CAB) pertaining to communicable diseases prevention related to dengue and zoonoses infection. The seroprevalence COVID-19 antibody serosurvey will also be carried out in this survey. This information will be reviewed and evaluated in order to improve the health service in our country. This survey involves;

    Image

    Seroprevalence study will involve activities such as blood sampling, information taking / short interview and self-administered questionnaires. The topics involve are seroprevalence COVID-19, hepatitis B and C, HIV stigma, dengue prevention and zoonotic infections related to household pet. During this first phase, scouting activities will be conducted to arrange appointments from the respondents and data collection activities will be conducted at nearby health facilities / clinics. A total of 10 ml of blood sample will be taken through venous puncture method for adult respondents while 3.5 ml - 5 ml for children and adolescents. All blood samples will be sent to the Institute for Medical Research (IMR) for COVID-19 laboratory tests while Hepatitis B and C laboratory tests will be sent to a certified private laboratory.

    Image

    Interview by telephone (Call assisted telephone interview, CATI) will involve similar respondents from the first phase. The topics consist of tuberculosis like symptoms, antibiotic use, HIV knowledge and malaria awareness.

    This survey will be conducted with cooperation from the State Liaison Officer (Communicable Disease unit) from each State Health department.

    Image
    0
    States
    0
    Enumeration Blocks (EB)
    0
    Houses
    0
    Respondents
    0
    Data collectors including Nurses

    NHMS 2020 Frequently Asked Questions (FAQs)

    Who involved in this survey?

    All household members from the randomly selected house will be interviewed and taken blood (Aged ≥ 1 year)

    Who will come to the house?

    The selected houses will be visited by the Data Collection Team consisting of 4 research assistants’ officers, a nurse and a team supervisor. Data collectors will be provided with:

    1. Official name tags for identification,
    2. Letter of appointment

    How and why is my house selected?

    The houses were randomly selected by the Department of Statistics Malaysia, where approximately 2000 houses representing urban and rural areas were selected throughout Malaysia

    What are the survey activities?

    1. Face to face interview
    2. Blood sampling for detection of Hepatitis B, C and Covid-19 antibody
    3. Self-administered Questionnaires

    How long does it take for an interview and blood sampling session?

    10 – 15 minutes

    How does blood collection will be conducted?

    All respondents aged 1 years old and above will be recruited for blood collection. Blood will be drawn from a venipuncture procedure. Volume of blood that will be drawn according to age and weight of respondent;

    1. >15 years old: 10 ml
    2. Children < 7 years old: 5 ml
    3. Children 7-15 years old: 5 ml

    Can the study or my participation be terminated early?

    Your participation in this study is voluntary and no termination will be applied unless you are known to have any non-eligibility criteria after study recruitment.

    Will the information obtained be kept confidential?

    All your information obtained in this study will be kept and handled in a confidential manner, in accordance with applicable laws and/or regulations. All information will be used for survey and research purposes only.

    What are the benefits of being in this survey?

    There will be no direct health benefits if you take part in this survey. However, information obtained from this study will help the policy makers to plan towards improving health services and disease control programmes in this country.

    If you are recruited for blood investigation, you will get information on your health status related to hepatitis B and C infections as Covid-19 antibody.

    Contact Us

    Address

    Institut Kesihatan Umum (IKU)
    Kompleks Institut Kesihatan Negara (NIH)
    No.1, Jalan Setia Murni U13/52
    Seksyen U13, Setia Alam
    40170 Shah Alam, Selangor


    Email

    nhms.iku@moh.gov.my
    m.hatta@moh.gov.my (Principal Investigator)


    NHMS Hotline

    Telephone: 03-3362 8793
    Fax: 03-3362 7801